Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Michael P. Gabay

Michael P. Gabay


Clinical Professor, College of Pharmacy - Pharmacy Practice
PGY2 Residency Program Director - Drug Information, College of Pharmacy - Pharmacy Practice
Clinical Pharmacist, Drug Information, College of Pharmacy - Pharmacy Practice
Director, Drug Information Group and Prior Authorization Programs, College of Pharmacy - Pharmacy Practice

Contact

Address:

833 S Wood St, Chicago, Illinois

Related Sites:

About Heading link

Overview:
Dr. Gabay is a drug information specialist who is the Director of the UIC Drug Information Group.

The Drug Information Group (DIG) is a fee-for-service business unit within the UIC College of Pharmacy. The DIG has a varied client listing including Cardinal Health, MedAssets, Baxter, Astellas Pharma, Takeda Pharmaceuticals, Postgraduate Healthcare Education, Scripps Health, Conduent, Optum, ConsortiEx, and the Illinois Department of Healthcare and Family Services, among others. To address the needs of these clients, the DIG offers a wide array of services including: responses to individual drug information requests, single drug, drug class, and disease state formulary reviews, continuing education programs for healthcare professionals, drug information slide kits, database development, writing projects including dossiers, standard response letters, global core response documents, manuscripts, newsletters, and posters, training programs for sales representatives and medical science liaisons, advisory board and consensus conference development, and drug information and literature evaluation courses.

Research Interests:
Dr. Gabay’s areas of interest include drug information, medication use evaluation, and legal issues related to healthcare.

Teaching Statement:
Dr. Gabay teaches pharmacy students in the drug information resources and literature evaluation/evidence-based medicine courses within the College of Pharmacy. He also precepts fourth year pharmacy students and PGY1/PGY2 residents on rotation in the Drug Information Group.

Teaching and Supervision Heading link

Spec Project in Pharm Pract (PMPR 390), 1/10/2022 – 4/29/2022
Journal Club and Advanced Lit (PMPR 330), 8/23/2021 – 12/3/2021
Journal Club and Advanced Lit (PMPR 330), 8/23/2021 – 12/3/2021
Evidence-Based Medicine (PHAR 440), 2/15/2021 – 4/30/2021
Evidence-Based Medicine (PHAR 440), 2/15/2021 – 4/30/2021
Evidence-Based Medicine (PHAR 440), 2/15/2021 – 4/30/2021
Evidence-Based Medicine (PHAR 440), 2/15/2021 – 4/30/2021
Evidence-Based Medicine (PHAR 440), 2/15/2021 – 4/30/2021
Intro to Drug Information (PHAR 438), 1/14/2019 – 2/15/2019

Selected Grants

PGY2 Residency in Drug Information, AbbVie., 3/2016 - 2017, Obligated Amount: $40000; Anticipated Amount: $40000

PGY2 Residency in Drug Information, AbbVie., 3/2015 - 2016, Obligated Amount: $40000; Anticipated Amount: $40000

Takeda Pharmaceuticals Residency Agreement FY16, Takeda Pharmaceuticals., 1/1/2015 - 12/31/2016, Obligated Amount: $96108; Anticipated Amount: $96108

PGY2 Residency in Drug Information, AbbVie., 3/2014 - 2015, Obligated Amount: $40000; Anticipated Amount: $40000

Takeda Residency Agreement, Takeda Pharmaceuticals., 1/1/2014 - 1/1/2016, Obligated Amount: $99270; Anticipated Amount: $99270

Takeda Residency Agreement, Takeda Pharmaceuticals., 7/1/2013 - 6/30/2014, Obligated Amount: $99270; Anticipated Amount: $99270

PGY2 Residency in Drug Information, AbbVie., 3/2013 - 2014, Obligated Amount: $35000; Anticipated Amount: $35000

PGY2 Residency in Drug Information, Abbott Fund., 3/2012 - 2013, Obligated Amount: $35000; Anticipated Amount: $35000

PGY2 Residency in Drug Information, Abbott Fund., 3/2010 - 2011, Obligated Amount: $49000; Anticipated Amount: $49000

Selected Publications

Gabay, Michael, Spencer, Samantha. (2021). Drug Interactions: scientific and clinical principles. Pharmacotherapy Self-Assessment Program. (pp. 7-28). American College of Clinical Pharmacy.

Gabay, Michael, Johnson, Philip, Fanikos, John, Amerine, Lindsey, Kienle, Patricia, Olsen, MiKaela, Roussel, Christine, Moody, Mary Lynn. (2021). Report on 2020 Safe to Touch Consensus Conference on Hazardous Drug Surface Contamination. American Journal of Health-System Pharmacy, 78, (17), 1568-1575. doi:10.1093/ajhp/zxab134.

Afanasjeva, Janna, Gabay, Michael, Poznanski, Thomas, Kerns, Stefanie. (2021). Transdermal Patch Administration and Magnetic Resonance Imaging (MRI)—2020. Hospital Pharmacy, 57, (1), 117-120. doi:10.1177/0018578720987138.

Afanasjeva, Janna, Burk, Muriel, Cunningham, Francesca Fran, Fanikos, John, Gabay, Michael, Hayes, Genevieve Jeni, Masters, Patricia L, Rodriguez, Ryan, Sinnett, Mark J. (2021). ASHP Guidelines on Medication-Use Evaluation.. American Journal of Health-System Pharmacy, 78, (2), 168-175. doi:10.1093/ajhp/zxaa393.

Gabay, Michael. (2020). RxLegal: The Evolving Legal Landscape of Telehealth. Hospital Pharmacy, 56, (6), 633-634. doi:10.1177/0018578720965428.

Gabay, MP, Sarna, KV, Griffin, T, Tarlov, E, Gerber, BS, Suda, KJ. (2020). Trends in gender composition on editorial boards in leading medicine, nursing, and pharmacy journals. Journal of the American Pharmacists Association. doi:10.1016/j.japh.2019.12.018.

Gabay, Michael, Hertig, John B, Degnan, Dan, Burger, Maureen, Yaniv, Angela, McLaughlin, Maureen, Moody, Mary Lynn. (2019). Third Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems—2018. American Journal of Health-System Pharmacy, 77, (3), 215-220. doi:10.1093/ajhp/zxz277.

Lee, Mary, Saseen, Joseph J, Beckman, Elizabeth, Coon, Scott, Gabay, Michael, Japs, Kelsey, Mangan, Brendan, McBane, Sarah, See, Sharon. (2019). Expanding the pharmacist’s scope of practice at the state level: Support for board certification within the credentialing process. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2, (6), 694-701. doi:10.1002/jac5.1192.

Gabay, MP, Grossman, S, Nathan, JP, Ipema, HJ, Ness, GL, Tierno, HE, Calip, GS. (2019). Survey of drug information centers in the United States-2018. American Journal of Health-System Pharmacy, 77, (1), 33-38. doi:10.1093/ajhp/zxz267.

Professional Leadership

Credentials: FCCP Committee, Board of Pharmacy Specialties, 10/1/2021 - Present

Council on Public Policy, American Society of Health-System Pharmacists, 1/1/2021 - Present

Pediatric Pharmacy Specialty Council, Board of Pharmacy Specialties, 1/1/2021 - 12/31/2023

Section Advisory Group on Clinical Leadership, American Society of Health-System Pharmacists, 2019 - 2020

Pediatric Pharmacy Specialty Council, Board of Pharmacy Specialties, 2019 - 2021

Credentials: FCCP Committee, American College of Clinical Pharmacy, 2019 - 2020

Education

Degrees:
Doctor of Jurisprudence (J.D.), Loyola University Chicago, United States, 2007
Pharm.D., University of Minnesota, United States, 1997
B.S, University of Minnesota, United States, 1997

Postgraduate Training:
Drug Information Specialty, University of Illinois at Chicago, United States, 1999
Pharmacy Practice, University of Minnesota Medical Center, United States, 1998

Licensures and Certifications

Medical Editing, University of Chicago, 1/1/2001 - Present
Board Certified Pharmacotherapy Specialist, Board of Pharmaceutical Specialties, 8/1/2000 - Present
Member, Illinois Bar, 5/1/2008 - Present